LSE: CIR       CIR
Last Price Today's Change   Day's Range   Trading Volume
19.50   +0.10 (0.52%)  18.415 - 20.50  3,979,613


Avg Volume (4 weeks):6,886,218
4 Weeks Range:16.25 - 24.945
4 Weeks Price Volatility (%):
52 Weeks Range:13.25 - 57.70
52 Weeks Price Volatility (%):
Average Price Target: 327.67
Price Target Upside/Downside: +308.17


No recent Headlines for this stock.

Business Background

Circassia Pharmaceuticals plc is a specialty biopharmaceutical company focused on allergy and respiratory diseases. The Company operates through three segments: Allergy, which relates to a range of immunotherapy development products for the treatment of allergy; NIOX, which relates to the portfolio of products used to improve asthma diagnosis and management by measuring fractional exhaled nitric oxide (FeNO), and Respiratory, which relates to the portfolio of asthma and chronic obstructive pulmonary disease product candidates. Its next-generation immunotherapy is in Phase III testing for cat allergy. Its lead asthma treatment targets substitution of GlaxoSmithKline's (GSK's) Flixotide pMDI. It is developing therapies targeting direct substitution of Seretide pMDI and Serevent pMDI. The Company is also developing a range treatment, including a fixed dose triple combination containing an inhaled corticosteroid, long-acting beta agonist and long-acting muscarinic antagonist.

  Be the first to like this.


2107  2164  644  2694 

Top 10 Active Counters
 LLOY 64.33+3.21 
 PREM 0.09-0.008 
 ORCP 1.30-0.075 
 UJO 0.16+0.007 
 BOU 0.024+0.001 
 BARC 182.48+10.62 
 RLD 0.36+0.06 
 VILX 0.464-0.023 
 TW 199.65+25.55 
 EUZ 0.025-0.001 
Partners & Brokers